1 / 11

Financing of Drug Trials: Influences and Consequences

This qualitative, systematic review explores the possible influences of pharmaceutical companies on the findings, protocols, and quality of drug trials. It discusses the impact of financing on the integrity and reliability of research.

apepper
Download Presentation

Financing of Drug Trials: Influences and Consequences

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  2. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  3. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  4. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  5. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  6. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  7. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  8. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  9. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  10. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

  11. Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Ludwig, W; Lieb, K The Financingof Drug Trials byPharmaceutical Companies andItsConsequences: Part 1. A Qualitative, Systematic Review oftheLiterature on PossibleInfluences on theFindings, Protocols, and Quality of Drug Trials DtschArzteblInt 2010; 107(16): 279-85; DOI: 10.3238/arztebl.2010.0279

More Related